Patients with mild Alzheimer’s disease over age 65 continue to derive benefit from DBS-f treatment

Share on facebook
Share on twitter
Share on pinterest

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 – 24 months) of the Phase II trial.

from News-Medical.Net Spinal Cord Injury News Feed https://ift.tt/2tn7TnI
via Medical.news

Subscribe to our Newsletter

Subscribe now to stay up to date on news and upcoming events. 

Share this post with your friends

Share on facebook
Share on google
Share on twitter
Share on linkedin

Leave a Reply

Your email address will not be published. Required fields are marked *